Académique Documents
Professionnel Documents
Culture Documents
ALFIN GIOVANI
2443014099
PROGRAM STUDI S1
FAKULTAS FARMASI
UNIVERSITAS KATOLIK WIDYA MANDALA SURABAYA
2018
ABSTRAK
ALFIN GIOVANI
2443014099
i
ABSTRACT
ALFIN GIOVANI
2443014099
ii
KATA PENGANTAR
Puji syukur penulis panjatkan kepada Tuhan Yang Maha Esa yang
telah memberikan rahmat dan karunia-Nya, sehingga skripsi dengan judul
“Studi Penggunaan Carboplatin Untuk Penderita Kanker Payudara Di
RUMKITAL Dr. Ramelan Surabaya” dapat terselesaikan. Penyusunan
skripsi ini dimaksudkan untuk memenuhi persyaratan untuk memperoleh
gelar Sarjana Farmasi di Fakultas Farmasi Univeritas Katolik Widya
Mandala Surabaya.
Penulis mengucapkan terima kasih kepada pihak-pihak yang telah
membantu selama proes pembuatan naskah skripsi ini, kepada:
1. Tuhan Yesus Kristus atas berkat yang diberikan kepada saya
sehingga naskah skripsi ini dapat terselesaikan dengan baik.
2. Drs. Didik Hasmono, MS., Apt selaku pembimbing I, Dra. Siti
Surdijati, MS., Apt selaku pembimbing II dan Drs. S. Joko Semedi,
Apt., Sp. FRS selaku pembimbing lapangan yang telah banyak
meluangkan waktu, memberikan ilmu, saran, pengarahan, petunjuk
dan motivasi selama bimbingan dari awal hingga akhir penyusunan
skripsi ini.
3. Tim dosen penguji Prof. Dr. dr. Paulus Liben, MS. dan Elisabeth
Kasih, S.Farm., M.Farm.Klin., Apt yang telah banyak memberikan
masukan dan saran demi perbaikan penyusunan naskah skripsi ini
dari awal hingga akhir.
4. Drs. Kuncoro Foe, Ph.D., G.Dip.Sc., Apt., Selaku Rektor
Universitas Widya Mandala Surabaya atas sarana dan prasarana
serta kesempatan yang diberikan untuk menempuh Pendidikan di
Fakultas Farmasi Universitas Katolik Widya Mandala Surabaya.
5. Sumi Wijaya, Ph.D., Apt., selaku Dekan Fakultas Farmasi
Universitas Katolik Widya Mandala Surabaya yang telah banyak
membantu dan memberikan fasilitas dalam penyusunan skripsi ini.
iii
6. Henry Kurnia Setiawan S.Si., M.Si., Apt., selaku Penasehat
Akademik yang selalu memberikan nasehat, semangat dan
dorongan selama saya kuliah di Fakultas Farmasi Universitas
Katolik Widya Mandala Surabaya.
7. Bapak dan Ibu dari Rekam Medik RUMKITAL Dr. Ramelan
Surabaya yang telah membantu dalam proses pengambilan data
selama skripsi ini.
8. Seluruh Dosen Pengajar Fakultas Farmasi Universitas Katolik
Widya Mandala Surabaya yang telah mendidik dan memberikan
ilmu yang banyak sekali selama saya kuliah dan menuntut ilmu di
Strata-I ini.
9. Bapak Hery dan Ibu Liliana selaku kakek dan nenek tercinta yang
selalu mendoakan dan selalu memberikan dukungan moril maupun
material serta semangat selama kuliah di Fakultas Farmasi. Terima
kasih atas kasih sayang dan cintanya.
10. Natania Imanuella Worotikan, yang selalu memberi semangat dan
motivasi dalam penyelesaian skripsi ini. Terima kasih telah
menemani dari awal perkuliahan hingga penyelesaian skripsi ini.
11. Sahabat dan teman-temanku Abdul Rozak, Yudha Adi, Mia Puji
Santoso, Saristisari, Anthony, Yahya Iqbal W, Prawijaya dan
Viviancio terimakasih atas semangat dan kerjasamanya selama ini.
12. Seluruh teman-teman angkatan 2014 yang tidak dapat saya
sebutkan satu persatu, terima kasih atas kebersamaan, dukungan
dan semangatnya selama penyusunan skripsi ini dan dalam Teman-
menuntut ilmu Strata-I di Fakultas Farmasi Universitas Katolik
Widya Mandala Surabaya.
13. Teman-teman BEM-FF UKWMS periode 2016/2017, terima kasih
atas kebersamaan, dukungan dan semangatnya selama ini.
14. Serta semua pihak yang telah memberikan bantuan baik secara
langsung maupun tidak langsung yang tidak dapat disebutkan satu
iv
persatu yang telah membantu penulis dalam penyusunan skripsi
ini.
Dengan keterbatasan pengalaman, pengetahuan maupun pustaka
yang ditinjau, penulis menyadari kekurangan dalam penulisan naskah
Skripsi ini. Akhir kata penulis sangat mengharapkan kritik dan saran agar
naskah skripsi ini dapat lebih disempurnakan.
Penulis
v
DAFTAR ISI
Halaman
ABSTRAK
.............................................................................................
.............................................................................................
i
ABSTRACT
...........................................................................................................
...........................................................................................................
ii
KATA PENGANTAR
...........................................................................................................
...........................................................................................................
iii
DAFTAR ISI
...........................................................................................................
...........................................................................................................
vi
DAFTAR TABEL
...........................................................................................................
...........................................................................................................
ix
...........................................................................................................
...........................................................................................................
DAFTAR GAMBAR
...........................................................................................................
...........................................................................................................
x
DAFTAR LAMPIRAN
...........................................................................................................
...........................................................................................................
xi
DAFTAR SINGKATAN
vi
...........................................................................................................
...........................................................................................................
xii
BAB 1. PENDAHULUAN
...........................................................................................................
...........................................................................................................
1
1.1 Latar Belakang
.....................................................................................
.....................................................................................
1
1.2 Rumusan Masalah
.....................................................................................
.....................................................................................
6
1.3 Tujuan Penelitian
.....................................................................................
.....................................................................................
6
1.3.1 Tujuan Umum…………………………………
.....................................................................................
1.3.2 Tujuan Khusus
.....................................................................................
1.4 Manfaat Penelitian
.....................................................................................
.....................................................................................
7
BAB 2. TINJAUAN PUSTAKA
...........................................................................................................
...........................................................................................................
8
2.1 Tinjauan Kanker Payudara
vii
.....................................................................................
.....................................................................................
8
2.1.1 Definisi
.....................................................................................
.....................................................................................
8
2.1.2 Epidemiologi
.....................................................................................
.....................................................................................
11
2.1.3 Etiologi
.....................................................................................
.....................................................................................
13
2.1.4 Manifestasi Klinik
.....................................................................................
.....................................................................................
14
2.1.5 Diagnosis
.....................................................................................
.....................................................................................
14
2.1.6 Patofisiologi
.....................................................................................
.....................................................................................
20
2.1.7 Stadium dan Klasifikasi Histologik
.....................................................................................
.....................................................................................
21
viii
Halaman
2.1.8 Klasifikasi Kanker Payudara
....................................................................................
....................................................................................
23
2.1.9 Stadium Kanker Payudara…………………….
24
2.1.10 Terapi Pengobatan Kanker Payudara
....................................................................................
....................................................................................
27
2.2 Kerangka Konseptual
....................................................................................
....................................................................................
38
BAB 3. METODE PENELITIAN
...........................................................................................................
...........................................................................................................
39
3.1 Rancangan Penelitian
....................................................................................
....................................................................................
39
3.2 Populasi dan Sampel
....................................................................................
....................................................................................
39
3.2.1 Populasi
....................................................................................
....................................................................................
39
3.2.2 Sampel
vii
....................................................................................
....................................................................................
39
3.2.3 Teknik Pengambilan Sampel
....................................................................................
....................................................................................
39
3.2.4 Kriteria Inklusi
....................................................................................
....................................................................................
40
3.2.5 Kriteria Eksklusi
....................................................................................
....................................................................................
40
3.3 Bahan Penelitian
....................................................................................
....................................................................................
40
....................................................................................
3.4 Instrumen Penelitian
....................................................................................
....................................................................................
40
3.5 Tempat dan Waktu Penelitian
....................................................................................
....................................................................................
40
3.6 Definisi Operasional
....................................................................................
....................................................................................
41
3.7 Metode Pengumpulan Data………………………….
viii
....................................................................................
....................................................................................
41
3.8 Analisis Data………………………………………...
....................................................................................
....................................................................................
41
3.9 Tata Laksana Penelitian…………...………………...
....................................................................................
....................................................................................
43
BAB 4. HASIL PENELITIAN DAN PEMBAHASAN
...........................................................................................................
...........................................................................................................
44
4.1 Data Karakteristik Pasien
....................................................................................
....................................................................................
44
4.1.1 Usia
.........................................................................
.........................................................................
44
4.1.2 Status Pembiayaan
.........................................................................
.........................................................................
45
.........................................................................
4.2 Diagnosis Penyakit Penyerta Pasien Kanker
Payudara
....................................................................................
....................................................................................
46
4.3 Data Terapi Pro Kemoterapi pada Pasien Kanker
Payudara
ix
....................................................................................
....................................................................................
47
Halaman
4.4 Data Terapi Post Kemoterapi pada Pasien Kanker
Payudara
....................................................................................
....................................................................................
48
4.5 Data Terapi Penggunaan Carboplatin Tunggal atau
Kombinasi Pasien Kanker Payudara..
....................................................................................
....................................................................................
48
4.6 Data Keluhan Terapi Pengobatan Carboplatin
Tunggal atau Kombinasi Pasien Kanker Payudara
....................................................................................
....................................................................................
50
4.7 Data Toksisitas Hematologi pada Pasien Kanker
Payudara Menurut Kategori ECOG
....................................................................................
....................................................................................
50
4.8 Data Kondisi Keluar Rumah Sakit (KRS) Pasien
Kanker Payudara
....................................................................................
....................................................................................
51
4.9 Data Pola Pengobatan Kemoterapi Non Operasi
Pasien Kanker Payudara
....................................................................................
....................................................................................
52
x
4.10 Data Pola Pengobatan Kemoterapi Pre Operasi
Pasien Kanker
Payudara………………………………...
....................................................................................
....................................................................................
53
4.10 Data Pola Pengobatan Kemoterapi Post Operasi
Pasien Kanker Payudara…………………………….
....................................................................................
....................................................................................
53
4.12 Pembahasan………………………………………….
....................................................................................
....................................................................................
54
BAB 5. KESIMPULAN DAN SARAN
...........................................................................................................
...........................................................................................................
83
5.1 Kesimpulan
....................................................................................
....................................................................................
83
5.2 Saran
....................................................................................
....................................................................................
84
DAFTAR PUSTAKA
...........................................................................................................
...........................................................................................................
85
LAMPIRAN
...........................................................................................................
...........................................................................................................
90
xi
xii
DAFTAR TABEL
Tabel Halaman
ix
Tabel Halaman
x
DAFTAR GAMBAR
Gambar Halaman
xi
DAFTAR LAMPIRAN
Lampiran Halaman
A Nota Dinas Penelitian..................................................................... 90
B Nilai Normal Data Laboratorium dan Data Klinik......................... 91
C Data Demografi Pasien................................................................... 93
xii
DAFTAR SINGKATAN
xii
CT : Computed Tomography
ER : Estrogen Reseptor
xiii